Abbott GMP compliance
This article was originally published in The Tan Sheet
Executive Summary
Firm expects FDA to begin re-inspection of diagnostics facility in "the next few weeks," Division VP-Investor Relations John Thomas says in Oct. 9 earnings call. Abbott would not comment on how long it expects the inspection to last, or whether it believes regulators will find the plant in compliance with GMPs...